MetLife Investment Management’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.29M Buy
11,387
+1,095
+11% +$124K 0.01% 1181
2025
Q1
$1.08M Sell
10,292
-190
-2% -$20K 0.01% 1326
2024
Q4
$1.12M Buy
10,482
+542
+5% +$58.1K 0.01% 1352
2024
Q3
$995K Hold
9,940
0.01% 1389
2024
Q2
$838K Buy
9,940
+1,143
+13% +$96.3K 0.01% 1440
2024
Q1
$643K Hold
8,797
﹤0.01% 1543
2023
Q4
$628K Hold
8,797
﹤0.01% 1558
2023
Q3
$527K Hold
8,797
﹤0.01% 1600
2023
Q2
$634K Buy
8,797
+699
+9% +$50.4K ﹤0.01% 1542
2023
Q1
$596K Sell
8,098
-519
-6% -$38.2K ﹤0.01% 1536
2022
Q4
$576K Sell
8,617
-5,196
-38% -$347K ﹤0.01% 1553
2022
Q3
$742K Hold
13,813
0.01% 1360
2022
Q2
$769K Hold
13,813
0.01% 1363
2022
Q1
$969K Buy
13,813
+4,894
+55% +$343K 0.01% 1347
2021
Q4
$859K Hold
8,919
0.01% 1193
2021
Q3
$775K Sell
8,919
-13,339
-60% -$1.16M 0.01% 1266
2021
Q2
$1.82M Sell
22,258
-416
-2% -$34K 0.02% 915
2021
Q1
$2.16M Sell
22,674
-1,769
-7% -$168K 0.02% 838
2020
Q4
$1.52M Sell
24,443
-649
-3% -$40.3K 0.01% 948
2020
Q3
$1.49M Sell
25,092
-522
-2% -$31K 0.02% 850
2020
Q2
$1.79M Sell
25,614
-1,544
-6% -$108K 0.02% 767
2020
Q1
$1.23M Sell
27,158
-973
-3% -$44.1K 0.02% 813
2019
Q4
$1.83M Sell
28,131
-3,217
-10% -$209K 0.02% 847
2019
Q3
$1.95M Sell
31,348
-2,222
-7% -$138K 0.02% 799
2019
Q2
$2.39M Sell
33,570
-1,321
-4% -$94.1K 0.03% 732
2019
Q1
$2.74M Sell
34,891
-795
-2% -$62.3K 0.03% 668
2018
Q4
$3.02M Buy
35,686
+20,728
+139% +$1.75M 0.04% 541
2018
Q3
$2.56M Hold
14,958
0.03% 756
2018
Q2
$1.93M Hold
14,958
0.02% 802
2018
Q1
$1.54M Hold
14,958
0.02% 859
2017
Q4
$1.28M Buy
+14,958
New +$1.28M 0.01% 935